ANNX
Price
$2.89
Change
+$0.08 (+2.85%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
317.07M
46 days until earnings call
OCUL
Price
$9.62
Change
+$0.16 (+1.69%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1.51B
39 days until earnings call
Interact to see
Advertisement

ANNX vs OCUL

Header iconANNX vs OCUL Comparison
Open Charts ANNX vs OCULBanner chart's image
Annexon
Price$2.89
Change+$0.08 (+2.85%)
Volume$65.35K
Capitalization317.07M
Ocular Therapeutix
Price$9.62
Change+$0.16 (+1.69%)
Volume$99.04K
Capitalization1.51B
ANNX vs OCUL Comparison Chart in %
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. OCUL commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and OCUL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ANNX: $2.89 vs. OCUL: $9.62)
Brand notoriety: ANNX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 140% vs. OCUL: 52%
Market capitalization -- ANNX: $317.07M vs. OCUL: $1.51B
ANNX [@Biotechnology] is valued at $317.07M. OCUL’s [@Biotechnology] market capitalization is $1.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANNX and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 3 bearish.
  • OCUL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANNX is a better buy in the short-term than OCUL.

Price Growth

ANNX (@Biotechnology) experienced а +17.96% price change this week, while OCUL (@Biotechnology) price change was +1.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.51B) has a higher market cap than ANNX($317M). OCUL YTD gains are higher at: 12.646 vs. ANNX (-43.665). OCUL (-176.35M) and ANNX (-180.76M) have comparable annual earnings (EBITDA) . OCUL has more cash in the bank: 350M vs. ANNX (264M). ANNX has less debt than OCUL: ANNX (28.3M) vs OCUL (76.2M). OCUL has higher revenues than ANNX: OCUL (59.6M) vs ANNX (0).
ANNXOCULANNX / OCUL
Capitalization317M1.51B21%
EBITDA-180.76M-176.35M102%
Gain YTD-43.66512.646-345%
P/E RatioN/AN/A-
Revenue059.6M-
Total Cash264M350M75%
Total Debt28.3M76.2M37%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIFEX12.38N/A
N/A
MFS Diversified Income R2
PJGRX48.80N/A
N/A
PGIM Jennison Growth R
PIPTX17.37N/A
N/A
Virtus KAR Global Quality Dividend I
MLVKX32.14N/A
N/A
BlackRock Advantage Large Cap Val K
MSTVX10.69N/A
N/A
Morningstar Alternatives

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+2.85%
IDYA - ANNX
47%
Loosely correlated
+0.82%
ZYME - ANNX
47%
Loosely correlated
+1.16%
CCCC - ANNX
46%
Loosely correlated
-2.63%
AURA - ANNX
46%
Loosely correlated
+1.55%
OCUL - ANNX
45%
Loosely correlated
+1.69%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+1.69%
EYPT - OCUL
58%
Loosely correlated
+0.62%
DNLI - OCUL
55%
Loosely correlated
-1.41%
NRIX - OCUL
52%
Loosely correlated
+2.33%
CRNX - OCUL
52%
Loosely correlated
+1.22%
RNA - OCUL
51%
Loosely correlated
-0.65%
More